Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes.
Kitaguchi T, Moriyama Y, Taniguchi T, Maeda S, Ando H, Uda T, Otabe K, Oguchi M, Shimizu S, Saito H, Toratani A, Asayama M, Yamamoto W, Matsumoto E, Saji D, Ohnaka H, Miyamoto N. Kitaguchi T, et al. Among authors: toratani a. J Pharmacol Toxicol Methods. 2017 May-Jun;85:73-81. doi: 10.1016/j.vascn.2017.02.001. Epub 2017 Feb 3. J Pharmacol Toxicol Methods. 2017. PMID: 28163191
CSAHi study: Evaluation of multi-electrode array in combination with human iPS cell-derived cardiomyocytes to predict drug-induced QT prolongation and arrhythmia--effects of 7 reference compounds at 10 facilities.
Kitaguchi T, Moriyama Y, Taniguchi T, Ojima A, Ando H, Uda T, Otabe K, Oguchi M, Shimizu S, Saito H, Morita M, Toratani A, Asayama M, Yamamoto W, Matsumoto E, Saji D, Ohnaka H, Tanaka K, Washio I, Miyamoto N. Kitaguchi T, et al. Among authors: toratani a. J Pharmacol Toxicol Methods. 2016 Mar-Apr;78:93-102. doi: 10.1016/j.vascn.2015.12.002. Epub 2015 Dec 4. J Pharmacol Toxicol Methods. 2016. PMID: 26657830
Effects and safety of ¹³¹I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: results from a multicenter observational registry.
Yoshinaga K, Oriuchi N, Wakabayashi H, Tomiyama Y, Jinguji M, Higuchi T, Kayano D, Fukuoka M, Inaki A, Toratani A, Okamoto S, Shiga T, Ito YM, Nakajo M, Nakajo M, Kinuya S; Drafting Committee for Guidelines on Internal Radiotherapy with ¹³¹I-MIBG; Japanese Society of Nuclear Medicine in Oncology and Imunology; Japanese Society of Nuclear Medicine. Yoshinaga K, et al. Among authors: toratani a. Endocr J. 2014;61(12):1171-80. doi: 10.1507/endocrj.EJ14-0211. Epub 2014 Sep 11. Endocr J. 2014. PMID: 25214026 Free article.
15 results